Lineus Medical

Lineus Medical, a medical device company focused on reducing IV complications, announced that the company's flagship product, SafeBreak Vascular, has received clearance from the U.S. Food and Drug Administration (FDA) for use in pediatric patients.

Lineus Medical continues to expand its distribution network for SafeBreak® Vascular. This time, it's in the veterinary space, with SafeBreak® Vascular Vet.

Lineus Medical is proud to announce its selection into the 2023 Fuel Accelerator Program.

Provides the Opportunity to Sell SafeBreak® Vascular in International Markets

Lineus Medical announces publication of the randomized controlled trial performed at Colorado State University Veterinary Teaching Hospital in the Journal of the American Veterinary Medical Association.

Lineus Medical continues to expand its patent portfolio with the issuance of two new patents. The first issued patent was a Japanese Utility Patent (JP7095097) for SafeBreak® Vascular, a break-away medical device that helps protect peripheral IV lines.

Contract awarded for products that bring improvement to health care industry

Lineus Medical announces the publication of a pivotal clinical study performed at Hartford Hospital, part of Hartford HealthCare in Hartford, Connecticut, in the March edition of The Journal of Infusion Nursing.

Lineus Medical signed on its fifth distributor in as many months as it continues to expand its distribution network with the addition of Clinical Technology, a specialty distributor of medical products based out of Brecksville, OH.

Lineus Medical has signed its first international distributor, ONEY of Seoul, South Korea.